New Issue: Science’s Impossible Questions. Read Now

Progress against Prions

Ideas for treating the human form of mad cow disease begin to emerge

Join Our Community of Science Lovers!


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


More than 200 cases of variant Creutzfeldt-Jakob disease, the human form of mad cow, have occurred worldwide since the 1990s. No accepted treatment exists for the devastatingly fatal disease or any of the others caused by infection with the malformed, malignant protein particles called prions. Giovanna R. Mallucci and her co-workers at the Institute of Neurology in London have performed an experiment in mice that could lay the groundwork for an eventual cure. Researchers genetically engineered mice to produce the protein PrP for only the first nine weeks after birth. PrP misfolds in the presence of prions, which causes it to produce more prions.

When both the altered mice and a normal group were injected with prions causing the illness called scrapie, both groups experienced a cognitive decline at first. The normal subjects continued to deteriorate. But by 12 weeks, the engineered group, without an ongoing supply of PrP, had recovered memory and normal behavior patterns. The absence of the natural protein did not appear to have an adverse effect on the restored rodents. If this approach proves itself further, it might lead to drugs or gene therapies that diminish PrP.

Until that happens, the possibility of prions infecting people through the blood supply remains an ever present fear. Robert Rohwer of the Veterans Affairs Medical Center in Baltimore and his colleagues invented a filter that might be able to purge red blood cells of prions. The team members began by searching through a library of millions of chemicals until they discovered a compound, L13, that readily sticks to prions. Scrapie-containing blood filtered through beads coated with L13 and then injected into hamsters did not cause disease in the animals, unlike tainted, unfiltered blood.

Gary Stix is the former senior editor of mind and brain topics at Scientific American.

More by Gary Stix
Scientific American Magazine Vol 298 Issue 1This article was published with the title “Progress against Prions” in Scientific American Magazine Vol. 298 No. 1 (), p. 50
doi:10.1038/scientificamerican0108-50a

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe